Table 1.
Diagnostic tests | Group 1 | Group 2 | P-value |
---|---|---|---|
Ocular Surface Disease Index | 6.94±9.29 (0–25), N=6 | 7.08±12.24 (0–33.3), N=7 | 0.98* |
SANDE (symptom frequency) | 1.92±2.11 (0–6), N=6 | 0.71±0.76 (0–2), N=7 | 0.184* |
SANDE (severity) | 1.25±1.47 (0–4), N=6 | 0.29±0.49 (0–1), N=7 | 0.13* |
Osmolarity | 302.4±13.59 (277–325), N=12 | 310.14±14.78 (288–342), N=14 | 0.18* |
Lissamine green staining (van Bijsterveld) | 1.25±1.06 (0–3), N=12 | 0.69±0.75 (0–2), N=14 | 0.18** |
Lissamine green staining (Oxford) | 0.5±0.52 (0–1), N=12 | 0.43±0.51 (0–1), N=14 | 0.74** |
Fluorescein staining (National Eye Institute/Industry Workshop) | 0.08±0.29 (0–1), N=12 | 0.07±0.27 (0–1), N=14 | 0.96** |
Tear breakup time | 13.83±6.01 (7–25), N=12 | 11.11±6.63 (5.5–26), N=14 | 0.29* |
Schirmer with anesthesia | 16±5.16 (10–25), N=12 | 15.36±1.34 (15–20), N=14 | 0.66* |
Notes:
Student’s t-test;
Mann–Whitney U-test; P<0.05. Data shown as mean ± standard deviation (range).
Abbreviation: SANDE, Symptom Assessment in Dry Eye.